tiprankstipranks
Trending News
More News >
Immuron Ltd (IMRN)
NASDAQ:IMRN

Compare Immuron (IMRN) vs. Competitors

Compare
205 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immuron
$0.82
$7.31M
-1.39
-61.33%
Can-Fite BioPharma
$4.05
$5.56M
-85.47%
0 Buy
1 Hold
0 Sell
Hold
Lipocine
$2.92
$45.41M
-8.05
80.18%
2 Buy
0 Hold
0 Sell
Moderate Buy
BioVie
$1.19
$8.75M
-0.13
-93.33%
0 Buy
0 Hold
0 Sell
Moderate Buy
Aspire Biopharma Holdings
$1.63
$5.36M
-0.02
-99.63%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMRN
Immuron
0.81
-1.23
-60.20%
CANF
Can-Fite BioPharma
4.04
-25.36
-86.26%
LPCN
Lipocine
8.18
3.75
84.65%
ADAP
BIVI
BioVie
1.16
-18.94
-94.23%
ASBP
Aspire Biopharma Holdings
1.55
-504.45
-99.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts